• Explore /
  • Poster
  • / Cetuximab and chemotherapy in the treatment of patients with initially “nonresectable” colorectal (CRC) liver metastases: Long-term follow-up of the CELIM trial.

Cetuximab and chemotherapy in the treatment of patients with initially “nonresectable” colorectal (CRC) liver metastases: Long-term follow-up of the CELIM trial.

Abstract Poster

Authors

null

Gunnar Folprecht

University Hospital Carl Gustav Carus, University Cancer Center / Medical Department I, Dresden, Germany

Gunnar Folprecht , Thomas Gruenberger , Wolf Bechstein , Hans-Rudolf Raab , Juergen Weitz , Florian Lordick , Joerg Thomas Hartmann , Hauke Lang , Tanja Trarbach , Jan Stoehlmacher-Williams , Torsten Liersch , Detlev Ockert , Dirk Jaeger , Ulrich Steger , Thomas Suedhoff , Claus-Henning Kohne

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT00153998

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3538)

DOI

10.1200/jco.2013.31.15_suppl.3538

Abstract #

3538

Poster Bd #

1D

Abstract Disclosures

Similar Posters

First Author: Gunnar Folprecht

First Author: Qi Lin

First Author: Marc Ychou

Poster

2016 Gastrointestinal Cancers Symposium

Conversion to resectability in unresectable metastatic colorectal cancer chemotherapy (mCRC) trials.

Conversion to resectability in unresectable metastatic colorectal cancer chemotherapy (mCRC) trials.

First Author: Sarah Chrabaszcz